Deprecated: Required parameter $cat_id follows optional parameter $type in /www/wwwroot/ebimall.com/systems/hong.php on line 2088

Deprecated: Required parameter $where follows optional parameter $tree_id in /www/wwwroot/ebimall.com/systems/hlb.php on line 3505
Chromatin Immunoprecipitation (ChIP) on Unfixed Chromatin from Cells and Tissues to Analyze Histone Modifications188bio精品生物—专注于实验室精品爆款的电商平台 - 蚂蚁淘旗下精选188款生物医学科研用品
您好,欢迎您进入188进口试剂采购网网站! 服务热线:4000-520-616
蚂蚁淘商城 | 现货促销 | 科研狗 | 生物在线

Chromatin Immunoprecipitation (ChIP) on Unfixed Chromatin from Cells and Tissues to Analyze Histone Modifications

INTRODUCTION

Incellsandtissues,thehistoneproteinsthatconstitutethenucleosomescanpresentmultiplepost-translationalmodifications,suchaslysineacetylation,lysineandargininemethylation,serinephosphorylation,andlysineubiquitination.Ontheirown,orincombination,thesecovalentmodificationsonthecorehistonesarethoughttoplayessentialrolesinchromatinorganizationandgeneexpressionineukaryotes.Importantly,patternsofhistonemodificationsmaybesomaticallyconservedandcan,thereby,maintainlocus-specificrepression/activityindefinedlineages,orthroughoutdevelopment.Indirectimmunofluorescencestudiesonculturedcellshavebeenpivotalinunravelingtherolesofhistonemodifications.However,toaddressindetailwhathappensatspecificsitesinvivo,chromatinimmunoprecipitation(ChIP)isthemethodofchoice.Here,wedescribehowChIPcanbeperformedonnon-fixedchromatinfromanimalcellsortissues(freshorfrozen)toanalyzehistonemodificationsatspecificchromosomalsites.Theseprotocolsaresuitableonlyforanalyzinghistonesandtheirmodifications.Forotherapplications,chromatinimmunoprecipitationshouldbeperformedoncross-linkedchromatin.

RELATEDINFORMATION

ThisChIPprotocolwasderivedfrommethodologiesoriginallydescribedbyO’NeillandTurner(1995).ItwaspublishedearlierontheWebsiteoftheEuropeanNetworkofExcellence"EPIGENOME"(www.epigenome-noe.net),andwasadaptedfromUmlaufetal.(2003).AnoverviewoftheprocedureisprovidedinFigure1.FollowingChIP,weusedifferentPCR-basedmethodsthatallowonetoanalyzealocusofinterestintheprecipitatedchromatin(seePCR-basedAnalysisofImmunoprecipitatedChromatinfordetails).

Figure 1Viewlargerversion(16K):[inthiswindow][inanewwindow]Figure1.Flowchartoftheproceduresusedtoinvestigatesite-specificcovalentmodifications(i.e.,methylationandacetylation)onhistones.Insummary,nucleiarepurifiedfromfresh/frozentissuesorfromcells,andthechromatin,afterfractionationwithmicrococcalnuclease(MNase),ispurifiedfromthenuclei.This"inputchromatin,"madeupoffragmentsofuptosevennucleosomesinlength,isincubatedwithanantiserumdirectedagainstthehistonemodificationofinterest.Theantibody-boundfractionisseparatedfromtheunboundfractionand,afterextractionofgenomicDNAfromtheboundandunboundfractions,PCRtechnologiesareappliedtospecificallyanalyzethegeneorchromosomalregionofinterest.PrecipitatedDNAscanbeusedasprobestohybridizeDNAtilingarrays(ChIPonchip)aswell.

MATERIALS

Reagents

100-bpDNAsizeladder(Promega)

Agarose

Antisera(affinity-purified)

Theseshouldberaisedagainsthistonepeptideswithmono-,di-,ortrimethylationoracetylationataspecificlysine/arginineresidueofinterest.Inaddition,includeacontrolprecipitationwithan(IgG)antiserumthatisnotdirectedagainstchromatinproteins.

Cellculturefromwhichnucleiaretobeextracted(1x107to1x108cellsarerequired;seeSteps9-16)

Cellculturemedium,appropriateforcellsofinterest(seeStep10)

recipecautionChIPelutionbuffer

recipecautionChIPincubationbuffer

recipecautionDialysis-lysisbuffer

recipecautionDNAloadingbuffer(6X)

Ethanol(70%,v/v)

cautionEthidiumbromidesolution(20mg/mlinH2O)

Glycogensolution(20mg/ml)(Roche)

cautionIsopropanol

cautionLiquidnitrogen(forfrozentissueonly;seeStep1)

Micrococcalnuclease(MNase;10units/µlin50%[v/v]glycerol)(AmershamBioscience)

Storein10-to20-µlaliquotsat–20°C.Eachaliquotshouldbeusedonlyoncetoensureequalenzymeactivityindifferentchromatinpreparations.

recipecautionMNasedigestionbuffer

recipeMNasestopsolution

recipeNaCl(5M)

recipecautionNucleipreparationbufferI,prechilledonice

recipecautionNucleipreparationbufferII,prechilledonice

recipecautionNucleipreparationbufferIII,prechilledonice

cautionPhenol:chloroform:isoamylalcohol25:24:1(v:v:v)

recipeForextractionofgenomicDNA,thephenolshouldbesaturatedbeforehandwith100mMTris-Cl(pH7.5)andstoredat4°Cunder10mMTris-Cl(pH7.5).

recipePhosphate-bufferedsaline(PBS),cold

ProteinA(e.g.,CL-4BSepharosefromAmershamBioscience)orproteinGSepharose

ProteinAandproteinGarebacterialcellwallproteinsthatbindtotheFcregionofantibodies.TheseproteinsarecovalentlycoupledtoSepharose.ThechoicebetweenproteinAorproteinGSepharosedependsonthenatureoftheantibodyusedforChIP.Ingeneral,proteinAworksbestforrabbitpolyclonalantiseraandformousemonoclonalantibodiesfromtheIgG2a,IgG2b,andIgG3subclasses.ProteinGSepharoseispreferredformouseIgG1monoclonalantibodiesandforpolyclonalantiserafrommouse,rat,sheep,andgoat.

cautionProteinaseK(10mg/ml)(optional;seeStep70)

Sodiumbutyrate(optional;foranalyzinghistoneacetylationonly)

Toanalyzehistoneacetylation,werecommendaddingsodiumbutyrate(toafinalconcentrationof5mM)tothesolutionsusedforthepurificationofnucleiandforthepreparationofinputchromatin.Sodiumbutyratepreventslossofhistoneacetylationviathenonspecificactionofendogenoushistonedeacetylases.

cautionSodiumdodecylsulfate(SDS;10%,w/v)

recipeTBEbuffer(1X)

recipeTEbuffer(1X,pH7.5)

Tissuesamples(freshorfrozen)fromwhichnucleiaretobeextracted(seeSteps1-8)

cautionTrypsinsolution(0.05%[w/v])(Sigma)

recipeTubingpreparationsolutionI

recipeTubingpreparationsolutionII

recipeWashingbufferA

recipeWashingbufferB

recipeWashingbufferC

Equipment

Centrifuges:

Bench-topcentrifugewithcoolingsystemfor1.5-mlmicrocentrifugetubes
Centrifugewithaswing-outbucketrotorfor15-mlpolypropylenetubes
High-speedcentrifugewithcoolingsystemandaswing-outbucketrotorfor14-mlpolypropylenetubes

Dialysistubing(0.5-mmthick,10-kDaporewidth)(VWRinternational)

Homogenizer,prechilledonice

Weuseatissuegrinder/homogenizer(fromBDH)thathasaglassmortar(tube)andapestlewithahardplastichead.Theclearancebetweenpestleandmortaris0.15-0.25mm.

Horizontalgelelectrophoresistankforagarosegels

Ice

Magneticstirrer(seeStep32)

Microcentrifugetubes(1.5mland2.0ml)

cautionChromatinimmunoprecipitationsandincubationswithProteinA(G)Sepharose(Steps44-69)areperformedinmicrocentrifugetubes.Thesetubesmaybesiliconizedbeforehand(e.g.,witha2%[v/v]dichloromethylsilanesolution)inordertopreventnonspecificassociationofchromatinandantibodiestotheinnerwallsofthetubes.Inourlaboratory,wehaveobtainedcomparableresultswithnonsiliconizedandsiliconizedmicrocentrifugetubes.

Microscope,invertedlight(optional;seeStep8)

Mortarandpestle,prechilledinliquidnitrogen(forfrozentissueonly;seeStep1)

Muslincheesecloth

PreparethecheeseclothbyrinsingwithH2Oandthenautoclaving.

Parafilm

Pasteurpipettes

Polypropylenetubes,14ml(e.g.,17x100-mmFalcontubes)and15ml(e.g.,17x120-mmFalconconicaltubes)

Rotatingwheelsat4°Candroomtemperature

Spectrophotometer

Trayforstaininggels(seeStep41)

Universaltubingclamps(5mm)(SpectrumLaboratories)

UVlamp

Vortexmixer

Waterbathsetat37°C

METHOD

NucleiPreparationfromTissuesandCells

Steps1-8describethepurificationofnucleifromtissue,whileSteps9-16describethepurificationofnucleifromculturedcells.Topreventchromatindegradation,allstepsofthenucleipurificationprocedureshouldbeperformedonice,orat4°C(e.g.,precoolthecentrifugerotors).Inaddition,onesetofmicropipettesshouldbededicatedonlytothepreparationofnuclei,chromatin,andChIPanalysis,toavoidDNAcontamination.Wearglovesthroughoutallprocedures,andrespectthesafetyrules,especiallywhenhandlingphenol.

PurificationofNucleifromTissue(2h)

1.Dissectfreshtissue(maximum0.2gintotal)andrinseitincoldPBS.SeeTroubleshooting.Formanytissuetypes,frozentissue(snap-frozeninliquidnitrogen)canbeusedaswell.Thistissueshouldfirstbecrunchedintopowderinamortarfilledwithliquidnitrogen;thispowderisusedforStep2.Themortarshouldbeprechilledwithliquidnitrogenandthetissuekeptconstantlyunderliquidnitrogen.
2.Homogenizethetissueinaprechilledglasshomogenizerwith5-10mlofice-coldnucleipreparationbufferI,untilnoclumpsofcellspersist(~10-20strokes).FilterthesuspensionthroughfourlayersofmuslincheeseclothmoistenedbeforehandwithnucleipreparationbufferI.
3.Transferthecellsuspensiontoa14-mlpolypropylenetube,andcentrifugethesamplesinaswing-outrotor(3000g,5min,4°C).
4.Pouroffthesupernatant,andresuspendthecellsin2mlofice-coldnucleipreparationbufferI.Add2mlofice-coldnucleipreparationbufferII,mixgently,andplacethetubesoniceamaximumof5minutes.SeeTroubleshooting.
5.Preparetwonew14-mlpolypropylenetubes,eachcontaining8mlofice-coldnucleipreparationbufferIII.Carefullylayer2mlofeachcellsuspension(fromStep4)ontoeach8-mlsucrosecushion.CovereachtubewithapieceofParafilm.
6.Centrifugethetubesinaprechilledswing-outrotor(10,000g,20min,4°C).Thenucleiwillformapelletatthebottomofthetube,whereasthecytoplasmiccomponentswillremaininthetoplayer.Atthisstep,thenuclearpelletshouldbewhite.
7.CarefullytakeoffthesupernatantwithaPasteurpipette.Thisisacriticalstep,asthetopsolution(whichcontainsthedetergentIGEPALCA-630)shouldnotcomeintocontactwiththenuclearpelletatthebottomofthetube.Onewaytoachievethisistoremovethesupernatantinaboutthreesteps,changingthePasteurpipetteeachtime.SeeTroubleshooting.
8.Resuspendthenuclearpelletin1mlofMNasedigestionbuffer,andkeepthesamplesonice.Ifpossible,MNasedigestion(Step23)shouldbestartedimmediately.Nucleicanbestoredforupto1dayat4°C.Atthispoint,thenucleicanbecountedusingamicroscopeslideforcountingcells.Thenumberofnucleiobtainedpergramoftissuevariesaccordingtotissuetype.Forliver,forexample,thisprotocolyields~2x109nuclei/gtissue.

NucleiPreparationfromCulturedCells(2h)

9.Culture1x107to1x108cells.Ensurethatthecellsarenotgrownbeyondsemiconfluency.
10.RinsethecellsinPBS,add2mloftrypsinsolution(foradheringcellsonly),andincubatethemat37°C.Whentrypsinationiscomplete,stopthereactionbyadding5mlofculturemediumtothecells.
11.Dividethecellsuspensionbetweentwo14-mlpolypropylenetubes,andcentrifugethesamplesinaswing-outrotor(4000g,5min,4°C).
12.Pouroffthesupernatant,andresuspendthecellsin2mlofice-coldnucleipreparationbufferI.Add2mlofice-coldnucleipreparationbufferII,mixgently,andplacethetubesoniceamaximumof5minutes.SeeTroubleshooting.
13.Preparetwonew14-mlpolypropylenetubes,eachcontaining8mlofice-coldnucleipreparationbufferIII.Carefullylayer2mlofeachcellsuspension(fromStep4)ontoeach8-mlsucrosecushion.CovereachtubewithapieceofParafilm.
14.Centrifugethetubesinaprechilledswing-outrotor(10,000g,20min,4°C).Thenucleiwillformapelletatthebottomofthetube,whereasthecytoplasmiccomponentswillremaininthetoplayer.Atthisstep,thenuclearpelletshouldbewhite.
15.CarefullytakeoffthesupernatantwithaPasteurpipette.Thisisacriticalstep,asthetopsolution(whichcontainsthedetergentIGEPALCA-630)shouldnotcomeintocontactwiththenuclearpelletatthebottomofthetube.Onewaytoachievethisistoremovethesupernatantinaboutthreesteps,changingthePasteurpipetteeachtime.SeeTroubleshooting.
16.Resuspendthenuclearpelletin1mlofMNasedigestionbuffer,andkeepthesamplesonice.Ifpossible,MNasedigestion(Step23)shouldbestartedimmediately.Nucleicanbestoredforupto1dayat4°C.Atthispoint,thenucleicanbecountedusingamicroscopeslideforcountingcells.Thenumberofnucleiobtainedpergramoftissuevariesaccordingtocelltype.

MicrococcalNuclease(MNase)FractionationandPurificationofChromatin

PreparationofDialysisTubing(2hincludingcoolingtime)

17.Cutthetubingintopiecesofconvenientlength(10-20cm).
18.Boilthetubesfor10minutesin0.5literoftubingpreparationsolutionI.
19.RinsethetubestwiceindistilledH2O.
20.Boilthetubesfor10minutesin0.5literoftubingpreparationsolutionII.
21.Allowthetubestocooldown,andstorethemintubingpreparationsolutionIIat4°C.Ensurethatthetubesareentirelysubmerged.
22.Beforeuse,washthetubingtwice,insideandout,withH2O.Severalbatchesofdialysistubingcanbepreparedandstoredat4°Cforseveralweeks.

MNaseFractionation(30min)

23.Aliquottheresuspendednuclei(fromStep8or16)intotwo1.5-mlmicrocentrifugetubes(500µlineachtube).
24.Add1µlofMNaseenzyme(10units/µlin50%[v/v]glycerol)toeachtube,andmixgently.
25.Incubatethetwotubesina37°waterbath.Onetubeshouldbeincubatedfor2minutes;theothertubeshouldbeincubatedfor5minutes.Keepthesetwodigestionsseparateinsubsequentsteps,untilfractionsarechosenforcombining(Step43).
26.Add20µlofMNasestopsolutiontoeachtube.
27.Chillthesamplesonice.

RecoveryofSolubleChromatinFractions(16h)

28.Centrifugethe1.5-mltubeswiththeMNase-digestednuclei(fromStep27)topelletthenuclei(10,000rpm,10min,4°C).
29.Transferthesupernatantintoanother1.5-mltube.Storeitforupto1dayat4°C.Thissupernatantcontainsthefirstsolublefractionofchromatin,S1,whichcomprisessmallfragmentsonly.Donotdiscardthepellet.
30.Carefullyresuspendthepelletin500µlofdialysis-lysisbuffer.Atthisstage,wenormallyproceedtoStep31;however,amoreexpedientlysis/dialysisprocedureusedinourlaboratoryhasyieldedchromatinfragmentsofcomparablequality.ItreplacesSteps31-34asfollows:
i.Afterresuspendingthepelletin500µlofdialysis-lysisbuffer,placethesamplesfor1hourat4°C.
ii.Centrifugethesamples(10,000rpm,10min,4°C)inamicrocentrifuge.
iii.ProceedwithSteps35-36.
31.Closeonesideofthewasheddialysistubing(fromStep22)withauniversalclosureclamp.Transferthe500µlofresuspendednuclei(fromStep30)intothedialysistube,andclosethesecondsidewithanotherclamp.
32.Submergethetubein1-2litersofdialysis-lysisbuffer.Performdialysisfor12-16hoursat4°Cwithconstantmildstirringusingamagneticstirrer.
33.Transferthedialyzednucleiintoa1.5-mlmicrocentrifugetube.
34.Centrifugethenuclei(10,000rpm,10min,4°C)inamicrocentrifuge.
35.Transferthesupernatantinanew1.5-mlmicrocentrifugetube.Storeitforupto1dayat4°C.Thisisthesecondsolublechromatinfraction,S2,comprisingthelargerfragmentsofchromatinthatwereremovedfromthenucleiduringlysis/dialysis(Step32).
36.Resuspendthepelletin50µlofdialysis-lysisbuffer.Storeitforupto1dayat4°C.ThisischromatinfractionP.

QualityControlofChromatin(3h)

37.Measuretheopticaldensity(OD)ofeachfractionat260nmusingaspectrophotometer.
38.Put0.5µgofeachfraction(S1,S2,andP)inseparate1.5-mlmicrocentrifugetubes.
39.Add2µlof6XDNAloadingbufferand1µlof10%SDStoeachtube.Adjustthevolumeto10µl,andmixgently.
40.Loadthesamplesontoastandard1.2%(w/v)agarosegel(~10-15cminlength)in1XTBE,withthe100-bpDNAladderasasizecontrol.Letthesamplesmigrateat2-3V/cmuntilthefastestblueMarkerintheDNAloadingbufferhasmigratedabouthalfwaydownthegel.
41.Stainthegelfor30minutesinatraywith500mlofH2Otowhich20µgofethidiumbromidehasbeenadded.
42.Removebackgroundstainingfromthegelbyrinsingitfor15minutesinH2O.
43.ObservethesizeofthechromatinfragmentsineachfractionbyviewingthegelunderaUVlamp,andtakeaphotograph.SeeFigure2foranexampleoftypicalS1andS2fractions,aswellasforadviceonwhichfractionstocombineforchromatinimmunoprecipitation.Thepelletfraction,P,consistsofchromatinfragmentsthatareusuallylongerthan5nucleosomesinlength.
Figure 2Viewlargerversion(32K):[inthiswindow][inanewwindow]Figure2.Photographofnativechromatinpreparationwithfragmentsof,onaverage,onetofivenucleosomesinlength.Forthisexperiment,nucleiwerepurifiedfromprimaryfibroblastsandincubatedwithMNasefor6,9,12,and15minutes(lanes1-4,respectively).TheS1fractionswereobtaineddirectlyafterMNasedigestion,whereastheS2fractionswererecoveredbyovernightdialysis.Bandscorrespondingtochromatinfragmentsofonenucleosome(mono)tofivenucleosomes(penta)inlengthareindicated(1.2%agarosegel).Fractions1and2ofS1werecombinedwithfractions3and4ofS2forsubsequentChIP.
SeeTroubleshooting.

ChromatinImmunoprecipitation

IncubationofChromatinwithAntiserum(16h)

44.MixcomparableamountsoftheS1andS2fractionsina1.5-mlmicrocentrifugetube(4-10µgintotal).ItisimportanttomixsimilaramountsofchromatinfromtheS1andS2fractions.ThisensuresthatchromosomalregionsthatarebothlessaccessibleandhighlyaccessibletoMNasearepresentintheinputchromatinthatwillbeusedforChIP.
45.Bringthevolumeto1mlwithChIPincubationbuffer.
46.Add5-10µgoftheantibodyofchoice.Inordertocontrolfornonspecificbackgroundsignal,itisimportanttoincludeacontrolprecipitationwithan(IgG)antiserumthatisnotdirectedagainstchromatinproteins.
47.Closethetubes,andsealthelidswithParafilm.
48.Rotatethetubesat20-30rpmfor12-16hoursat4°C.Duringthisincubationtime,theantibodieswillbindtotheirspecificepitopes.SeeTroubleshooting.

PreparationofProteinA(G)Sepharose(45min)

49.Weigh0.25gofproteinA(orG)Sepharosebeadsintoa14-mlpolypropylenetube.
50.Add10mlofH2O,andmix.
51.Centrifugethetubesfor3minutesat1500ginaswing-outrotor,anddiscardthesupernatant.
52.RepeatSteps50and51fourtimes.
53.Add1mlofH2O,andresuspendthebeads.
54.Distribute100-µlaliquotsinto101.5-mlmicrocentrifugetubes.Storethesealiquotsat4°C.Thesealiquotsareusedfortheextractionofantibody-boundchromatinfromChIPexperiments(startinginStep55).

ExtractionofImmunoprecipitatedChromatinwithProteinA(G)Sepharose(6-7h)

55.Add50µlofproteinA(orG)Sepharose(fromStep54)toeachtube(fromStep48).
56.Rotatethetubesat20-30rpmfor4hoursat4°C.
57.Centrifugethetubesat1500ginaswing-outrotorfor3minutes.
58.Transferthesupernatanttoa2-mlmicrocentrifugetube.Storeitat4°C.Thisfractioncontainsthechromatinthatdidnotlinktotheantibody(i.e.,the"unboundfraction").
59.ResuspendtheSepharosebeadsin1mlofwashingbufferA.
60.Transfertheresuspendedbeadstoa15-mlFalcontube.
61.Bringthetotalvolumeto10mlwithwashingbufferA.Mixbriefly.
62.Centrifugefor3minutesat1500ginaswing-outrotorat4°C.Carefullydiscardthesupernatant.
63.Resuspendthebeadsin10mlofwashingbufferB.Brieflymix.
64.Centrifugefor3minutesat1500ginaswing-outrotorat4°C.Carefullydiscardthesupernatant.
65.ResuspendtheSepharosebeadsin10mlofwashingbufferC.
66.Centrifugefor3minutesat1500ginaswing-outrotorat4°C.Carefullydiscardthesupernatant.
67.Toelutethechromatin,resuspendtheSepharosebeadsin500µlofChIPelutionbuffer,andtransferthesampletoa1.5-mlmicrocentrifugetube.
68.Incubatethesamplesfor~30minutesatroomtemperatureonarotatingwheelat20-30rpm.Afterthisincubation,centrifugefor3minutesat1500ginamicrocentrifugeatroomtemperature.
69.Carefullytransferthesupernatantintoa2-mlmicrocentrifugetube.Storeitat4°C.ThistubecontainsthechromatinelutedfromtheSepharosebeads(i.e.,the"boundfraction").SeeTroubleshooting.

DNAExtractionfromPrecipitatedChromatin(3h)

70.Add500µlofphenol:chloroform:isoamylalcohol(25:24:1,v:v:v)tothebound(Step69)andunbound(Step58)fractions.TheDNAextractionsfromtheimmunoprecipitatedchromatinfractionsmightbeslightlyenhancedbyincludingaproteinaseK(PK)digestionstepjustbeforephenol:chloroform:isoamylalcoholextraction.ForPKdigestion,addPKtoeachsample(toafinalconcentrationof100µg/ml),andincubatethesamplesfor1hourat50°C.
71.Vortexthesamplesfor30seconds.
72.Centrifugethesamplesat13,000rpm(~15,000g)for15minutesinamicrocentrifuge.
73.Carefullytransfertheupper(aqueous)phasetoanother2-mlmicrocentrifugetube.
74.AddNaCltoafinalconcentrationof250mM.
75.Add10-20µgofglycogen,andmix.BecausetheDNAconcentrationintheboundfractionisusuallylow,werecommendtheuseofglycogenasacoprecipitator.
76.Add1volumeofisopropanol,andmix.
77.Keepthesamplesforatleast2hoursat-80°C.
78.Centrifugethesamplesat13,000rpminamicrocentrifugefor30minutes.Carefullydiscardthesupernatant.
79.Rinseeachpelletwith1mlof70%(v/v)ethanol.
80.Centrifugethesamplesat13,000rpmfor5minutesinamicrocentrifuge.Carefullydiscardthesupernatant.
81.Drythepelletsfor5-10minutesatroomtemperature,andresuspendeachpelletin10-50µlof1XTEbuffer.TheDNAsamplescanbestoredat4°C.

AssessmentofPrecipitatedChromatin

82.MeasuretheOD260ofeachsample(fromStep81)inordertocalculatehowmuchDNAtouseasatemplateinthesubsequentPCRamplification(seePCR-BasedAnalysisofImmunoprecipitatedChromatin).TheratiooftheDNAintheboundfractionversusthetotalstartingmaterial(correspondingtotheboundandunboundfractionstogether;thisvaluewasobtainedatStep37)indicatestheefficiencyoftheChIPassay,asitrepresentsthepercentageofimmunoprecipitatedchromatin.Inastandardanalysisofhistonemodifications,nomorethan15%oftheinputnativechromatinshouldbeprecipitated.However,thisdependsonthenatureandtheabundanceofthehistonemodifications,andonthecharacteristicsandconcentrationsoftheantibodiesused(seeDiscussion).

TROUBLESHOOTING

Problem:Howmuchtissue(andwhichkind)mustbeusedtopurifyenoughnucleiforaChIPexperiment?

[Step1]

Solution:Thisprotocolworkswellontissues,suchasliver,brain,lung,andplacenta,andalsoonearlymammalianembryos.Inourlaboratory,forinstance,wehaveperformedstudieson8.5-9.5d.p.c.mouseembryosandplacentas(Umlaufetal.2004).Some60dissectedembryoswereusedforeachChIPexperiment.Nomorethan~0.2goftissueshouldbeusedforthevolumesandtubesizesindicatedintheprotocol.

Problem:Howcantheyieldofintactnucleibemaximized?

[Steps4and12]

Solution:AtStep4(or12)ofthenucleipurificationprocedure,itiscriticalnottoextendtheincubationinnucleipreparationbufferIIfor>10minutes.Forthatreason,Step5shouldbeinitiatedafter5minutesofincubationinordertocommencecentrifugation(Step6)atexactly10minutesaftertheadditionofnucleipreparationbufferIIinStep4.Longerincubationscangreatlyreducetheyieldofintactnuclei.Formanytissues(liver,kidney,placenta),afinalconcentrationof0.2%ofthenonionicdetergentIGEPALCA-630(innucleipreparationbufferII)willbeenoughtolysethecellularmembranesduringthe10-minuteincubation.However,werecommendtesting0.4%IGEPALCA-630forothertissues.Forinstance,thishigherconcentrationofdetergentslightlyimprovestheyieldofnucleifrombrainandmuscletissues.

Problem:Isitaproblemifthetoplayer(containingtheIGEPALCA-630)comesintocontactwiththenucleipellet?

[Steps7and15]

Solution:AtStep7(or15),itisessentialthatnotracesofthetoplayer(containingtheIGEPALCA-630)comeintocontactwiththenucleipellet(evensmalltracesofIGEPALCA-630mayaberrantlyaffectthesubsequentdigestionofchromatinbyMNase).Usually,weremovethetoplayerandthesucrosecushionfromthetubebyusingPasteurpipettes.Thisisdonebyaspiratingfromthesurfaceofthesolution,whilechangingthePasteurpipetteveryoften.Ifthetoplayerneverthelesscomesincontactwiththenucleipellet,thepelletshouldbegentlyrinsedoncewith1mlofnucleipreparationbufferIIIbeforeproceedingwithStep8(or16).

Problem:Whatcanbedoneif,aftertheMNasedigestion,thechromatinappearstobedigestedtoomuchortoolittle?

[Step43]

Solution:FractionationofchromatindependsonthebatchofMNaseused,theconcentrationofthenucleiinthetube,thetimeofincubation,andthetissuetypefromwhichthenucleiwerepurified.Ifoneobservestoomuchdigestionofthechromatin(i.e.,almostallchromatinisdigestedtomono-anddinucleosomefragments),alowerconcentrationofMNaseshouldbeused.Inversely,incaselittlematerialisobtainedintheS1fraction,theamountofenzymeshouldbeincreased.

Problem:WhatcanbedonetoimproveChIPwhenusingchickenantiserathatdonotbindwelltoeitherproteinAorproteinG?

[Step47]

Solution:Werecommendadding5µgofarabbitanti-chickenantiserumdirectlyafterStep47forasecondprecipitationof3-4hours,beforeproceedingwiththeextractionoftheantibody-boundchromatin.

Problem:Whenanantiserumisusedforthefirsttime,howdoesoneverifythatthehistonemodificationitisdirectedagainsthasbecomeenrichedintheantibody-boundfraction?

[Step69]

Solution:Thiscanbedonebypurifyingthehistoneproteinsfromtheantibody-boundfraction(fromStep69),followedbyelectrophoresisthroughacid-urea-Tritongels.Afterelectrophoresis,proteinsareWestern-blottedtonylonfilters,whichareimmunostainedwiththeantiserumfollowingstandardprocedures(Gregoryetal.2001).

DISCUSSION

Therearedifferentwaystoobtaininputchromatin.Severalgroupsinthefieldprepare"cross-linkedchromatin,"forexample,bychemicallycross-linkingproteinsandDNAwithspecificsubstancessuchasformaldehyde.However,usuallyonlyasmallfractionofthechromatinisprecipitated,andthismethodreliesonrandomshearingaftercross-linking,whichdoesnotalwaysproducesmall-enoughchromatinfragmentsattheregionsofinterest.Forthisreason,andtobeabletoconductexperimentsonfreshandfrozentissues,weandothershavepreferredtomakeuseof"nativechromatin."Inourprotocol(Fig.1),thechromatinisfractionatedbyincubationofpurifiednucleiwithmicrococcalnuclease(MNase),anenzymethatcleavespreferentiallyatthelinkerDNAbetweenthenucleosomes.ByperformingpartialdigestionswithMNase,itispossibletoobtainnativechromatinfragmentsof,onaverage,onetofivenucleosomesinlength(Fig.2).Theseoligo-nucleosomefragmentsarepurifiedfromthenucleiandarethenusedtoperformChIP.ThechoiceofnativechromatinastheinputmaterialforChIPisadvantageousbecausetheepitopes,recognizedbytheantibody,remainintactduringthechromatinpreparation.Asaconsequence,nativechromatintendstogivehigherlevelsofprecipitationforaspecifichistonemodificationthanformaldehydecross-linkedchromatin.Becausefractionationoccursbetweenthenucleosomes,ratherthanrandomly,precipitatednativeoligo-nucleosomefragmentsarealsoparticularlysuitabletobeusedfor"ChIPonchip."InarecentChIPonchipstudy(Bernsteinetal.2006),bothnativeandformaldehyde-cross-linkedchromatinwereprecipitatedwithantiseraagainsthistonemodifications.DNAsamplesextractedfromtheprecipitatedchromatinwereusedasprobestohybridizeDNAtilingarrayscoveringmanylargechromosomalregio,ns.Inthislarge-throughputstudy,resultsobtainedwithnativechromatinwereverysimilartothoseobtainedwithcross-linkedchromatin.Forlocus-specific,smaller-scalestudies,amplificationbythepolymerasechainreaction(PCR)remainsthemethodofchoice.DifferentPCR-basedapproachescanbeusedtodeterminehowmuchDNAisprecipitatedatasiteofinterest(seePCR-basedAnalysisofImmunoprecipitatedChromatin).

AlthoughChIPispresentlythebestmethodologytoanalyzehistonemodificationsatspecificchromosomalloci,ithasseverallimitations.First,unlikeDNAmethylationstudies,ChIPdoesnotallowanalysisofhistonemodificationsinindividualcellsoronindividualchromosomes.ChIPstudiesarealwaysperformedonpopulationsof(cultured)cellsorontissuesamplescomprisingmanycells.Moreover,althoughsequentialprecipitationswithdifferentantiseracanbedone(Bernsteinetal.2006),orantiseraagainstcombinationsofdifferenthistonemodificationscanbeused,itisnoteasytodeterminewhethertherearespecificcombinationsofcovalentmodificationsonindividualhistonesatagivenlocus.Again,thisisbecausemanycellsareusedforchromatinpurificationandChIP,andchromatinisusuallyfractionatedintofragmentsthatcomprisemultiplenucleosomes.Last,itshouldbenotedthatquantificationofthelevelsofhistonemodificationsatspecificchromosomallociisdifficulttoobtainbyChIP,becauselevelsofprecipitationdonotdependsolelyonthelocalabundanceofthemodificationstudied.Theyalsodependonthequalityofthepreparedchromatin,onthespecificityandconcentrationoftheantiserumused,andontheglobalabundanceofthehistonemodificationthatisbeingstudied.Factorsthatcaninfluencetheoutcomeoftheexperimentare(1)thedistributionofthehistonemodificationsonthechromosomes,(2)theamountofantiserumused,and(3)the"strength"oftheantibodies(i.e.,theaffinityfortheirepitope).Ontheotherhand,theefficiencyofprecipitationofmodifiedhistonesatalocusofinterestgreatlydependsonwhetherthemodificationiscommonorrareinthegenome.Forinstance,araremodification(e.g.,H3-K4methylation)givesusuallygoodprecipitationatthesitewhereitispresent.Thiscanbeexplainedbythefactthat,intheChIP,thequantityofantibodyaddedtothetubeishighenoughtoprecipitateallthechromatinthatcarriesthatspecificmodification.However,foramodificationthatisabundantinthegenome,theindicatedamountofantibody(5-10µg)sometimesdoesnotprecipitateallthechromatinthathasthemodification.Thesedifferentfactorsshouldbetakenintoaccountwhencomparingdifferentchromatinimmunoprecipitationexperiments.

ACKNOWLEDGMENTS

WethankRichardGregoryandDavidUmlauffordesignofmethodologies,andBryanM.TurnerandLauraP.O’Neill(Birmingham,UK)forintroducingustoChIPonunfixedchromatin.TheCNRS,theAssociationpourlaRecherchesurleCancer(ARC),andtheESFEuroCORESProgrammeEuroSTELLSareacknowledgedforgrantsupport.


新闻动态
行业前沿
技术文章
最新产品